Clinical Chemistry AACC Online Job Center spacer gif
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2003.026484v1, 2004; 10.1373/clinchem.2003.026484
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.026484v1
50/5/846    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, K. M.
Right arrow Articles by Press, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, K. M.
Right arrow Articles by Press, R. D.

Received on September 7, 2003
Accepted on February 12, 2004

Molecular Diagnostics and Genetics

Quantitative Real-Time PCR with Automated Sample Preparation for Diagnosis and Monitoring of Cytomegalovirus Infection in Bone Marrow Transplant Patients

Kyeong Man Hong 1, Hazim Najjar 2, Mary Hawley 2, Richard D. Press 2*

1 Department of Pathology, Oregon Health & Science University, Portland, OR 97201, and Current address: Laboratory of Population Genetics, National Cancer Institute, Bethesda, MD 20892
2 Department of Pathology, Oregon Health & Science University, Portland, OR 97201

* To whom correspondence should be addressed. E-mail: pressr{at}ohsu.edu.

Background: In bone marrow and stem cell transplant patients, the widespread use of preemptive cytomegalovirus (CMV) antiviral therapy necessitates faster, more precise, and more sensitive quantitative laboratory methods for serial viral load monitoring.

Methods: We quantified CMV viral load assay by real-time PCR after plasma DNA was prepared by an automated robotic workstation. Fluorescent hybridization probes were directed at the glycoprotein B (gB) gene (or EcoRI D region) of CMV. The {beta}-globin gene was amplified in parallel to control for the efficiency of the extraction and PCR steps. Samples were collected from patients for whom final diagnoses were divided based on other tests and clinical history.

Results: The assay was linear (R = 0.999) from 125 to 5 x 109 copies/mL with a PCR efficiency of 1.975 (gB) or 2.02 (EcoRI D). The viral loads determined by PCRs directed at these two different viral targets were no different (n = 53; R = 0.928). The interassay CV was 3.5%, and the intraassay CV was 1-4%. Compared with a commercially available quantitative competitive PCR assay (Roche Monitor; R = 0.59), the mean results were 3.1 times higher (mean ratio; P = 0.002). The diagnostic sensitivity and specificity were 96% and 100%, respectively (n = 147), compared with 74% and 98% for a qualitative competitive PCR assay (Roche Amplicor). On a subset of samples, sensitivity of viral culture was 50% (n = 44). Of 1115 clinical referral samples from 252 patients, 10% of the samples and 18% of the patients had low-level CMV viremia (median, 500 copies/mL). In this predominantly (85%) bone marrow transplant testing cohort, serial CMV viral load results were the predominant clinical trigger for the initiation, monitoring, and cessation of preemptive antiviral therapy.

Conclusions: The combination of automated DNA preparation and semiautomated real-time fluorescent PCR detection allows for a sensitive, precise, and accurate high-throughput assay of CMV viral load that can be used as the laboratory trigger for preemptive antiviral therapy.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Mol. Diagn.Home page
T. Zhang, S. Grenier, B. Nwachukwu, C. Wei, J. H. Lipton, S. Kamel-Reid, and the Association for Molecular Pathology Hematopath
Inter-Laboratory Comparison of Chronic Myeloid Leukemia Minimal Residual Disease Monitoring: Summary and Recommendations
J. Mol. Diagn., September 1, 2007; 9(4): 421 - 430.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al.
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. B. Nye, A. R. Leman, M. E. Meyer, M. A. Menegus, and P. G. Rothberg
Sequence Diversity in the Glycoprotein B Gene Complicates Real-Time PCR Assays for Detection and Quantification of Cytomegalovirus
J. Clin. Microbiol., October 1, 2005; 43(10): 4968 - 4971.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
W. Habbal, F. Monem, and B. C. Gartner
Errors in Published Sequences of Human Cytomegalovirus Primers and Probes: Do We Need More Quality Control?
J. Clin. Microbiol., October 1, 2005; 43(10): 5408 - 5409.
[Full Text] [PDF]




spacer gif
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.